C. Locher

发表

Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans.

J. Levy, A. Haase, G. Reyes-Terán, 1998, Archives of pathology & laboratory medicine.

Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases

D. Lin, S. Govindarajan, S. Bass, 2007, Proceedings of the National Academy of Sciences.

Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.

J. Levy, C. Locher, N. Dowell, 2005, The Journal of general virology.

Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element.

J. Levy, C. Locher, B. Ashlock, 2002, DNA and cell biology.

Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboons.

J. Levy, K. Murthy, K. Brasky, 2003, AIDS research and human retroviruses.

Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation.

R. Langer, J. Levy, D. Putnam, 2003, Immunology letters.

Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine.

J. Levy, C. Locher, B. Ashlock, 2004, DNA and cell biology.

Immune responses in baboons vaccinated with HIV‐2 genetic expression libraries

S. Johnston, K. Sykes, D. Blackbourn, 2002, Journal of medical primatology.

Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons.

J. Levy, D. Blackbourn, C. Locher, 1999, Immunology letters.

CD8+ cells from HIV‐2‐infected baboons control HIV replication

J. Levy, K. Murthy, K. Brasky, 1997, AIDS.

Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants.

A. Vlietinck, B. van Poel, D. V. Vanden Berghe, 1995, Journal of ethnopharmacology.

Suppression of viral replication in a long-term nonprogressing rhesus macaque experimentally infected with pathogenic simian immunodeficiency virus (SIV).

D. Fuchs, U. Dittmer, C. Stahl‐Hennig, 1998, Clinical Immunology and Immunopathology.

Antiviral activity of Hawaiian medicinal plants against human immunodeficiency Virus Type-1 (HIV-1).

E. De Clercq, R. Pauwels, M. Witvrouw, 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.

C. Schmaljohn, R. Whalen, R. Bakken, 2009, Vaccine.

Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.

J. McBride, W. A. Siddiqui, S. P. Chang, 1996, Experimental parasitology.

The CD8+ T Cell Noncytotoxic Antiviral Responses

J. Levy, Maelig G. Morvan, C. Locher, 2021, Microbiology and Molecular Biology Reviews.

Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies

V. Heinrichs, R. Whalen, C. Locher, 2004, Expert opinion on biological therapy.

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.

J. Levy, S. Staprans, S. Shiboski, 2004, Vaccine.

Increased Virus Replication and Virulence after Serial Passage of Human Immunodeficiency Virus Type 2 in Baboons

N. Kiviat, J. Levy, P. Rácz, 2003, Journal of Virology.

Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development

J. Levy, P. Rácz, C. Locher, 2001, Immunological reviews.

Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons.

J. Levy, G. Reyes-Terán, K. Murthy, 1998, AIDS research and human retroviruses.

Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response.

J. Levy, G. Reyes-Terán, K. Murthy, 1997, The Journal of infectious diseases.

Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination.

J. Kahn, E. Collisson, J. Levy, 1999, AIDS research and human retroviruses.

Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2.

J. Levy, Y. Sun, S. Barnett, 1996, Virology.

Development of novel vaccines using DNA shuffling and screening strategies.

J. Punnonen, R. Whalen, N. Soong, 2004, Current opinion in molecular therapeutics.

Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodies.

C. Locher, L. Tam, 1993, Vaccine.

DNA shuffling and screening strategies for improving vaccine efficacy.

J. Punnonen, R. Whalen, M. Paidhungat, 2005, DNA and cell biology.

5HT1A Serotonin Receptor Agonists Inhibit Plasmodium falciparum by Blocking a Membrane Channel

P. Ruben, J. Gut, P. Rosenthal, 2003, Antimicrobial Agents and Chemotherapy.

CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.

J. Levy, K. N. Bossart, E. Barker, 1996, The Journal of general virology.

Three matrix metalloproteinases form a non-covalent association with the rhoptry-associated protein-1 of Plasmodium falciparum.

F. Vandekerckhove, C. Locher, L. Tam, 1992, Biochimica et biophysica acta.